# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Frédéric Chopin (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI020-SYN-TD
- Date: 1838-03-17
- Fictional facility: St. Posthumous Health Center
- Fictional author: Matthias Lindqvist, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Three months of cough, two weeks of blood-streaked sputum, night sweats, and weight loss: chest X-ray and CT, sputum samples, blood tests, home airborne isolation, and a report of suspected tuberculosis to the health department. **S**

## Historical basis

- Fryderyk Franciszek Chopin was born in the village of Żelazowa Wola, in Mazovia, on March 1, 1810, according to his own statements and his family's; his baptismal certificate, written several weeks after the birth, gives February 22. **D**
- His father, Mikołaj (Nicolas) Chopin, was a Frenchman from Lorraine who settled permanently in Poland and brought up his children as Poles; the family moved to Warsaw a few months after Fryderyk's birth. **D**
- In 1827 the youngest of the Chopin children, his sister Emilia, died of tuberculosis. **D**
- A review of the documentary sources reports recurrent episodes of cough, fever, headaches, and swollen lymph nodes beginning in his teens. **D**
- He left Warsaw on November 2, 1830, never to return, reached Paris in September 1831, and in 1834 chose the status of a political refugee rather than apply to the Russian embassy for a passport. **D**
- In Paris his most important source of income was giving lessons; he became a popular teacher, and although ranked among the greatest pianists of his time, he disliked public performances, appeared rarely, and preferred an intimate group of listeners. **D**
- In 1836 a proposal of marriage was accepted on condition that he take better care of his health; the engagement ended a year later, the family of his fiancée being disturbed by the bad state of his health, as he had been seriously ill in the winter. **D**
- He met the writer George Sand in Paris in 1836; their relationship, which began soon after, lasted nearly ten years. **D**

12 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- He has coughed for about three months, now with streaks of blood, sweats at night, and has lost weight; he wants to know what is wrong. **S**
- He teaches piano at home and performs; he wants to know when he can teach again and whether his students are at risk. **S**
- He is afraid his students and neighbors will shun him if they learn he may have tuberculosis. **S**

## Strengths and supports

- Born in Poland to a French father and a Polish mother; left home at 20 and has not been back; sources of support he names: a close circle of friends from home, his students, and his music **S**

## Medications and allergies

- No medications before this visit. **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- 1820s: Recurrent episodes of cough, fever, headaches, and swollen lymph nodes in his teens **D** (CLM-0004)
- winter of 1836 to 1837: Serious illness; cause not recorded in the cited source **D** (CLM-0007)

## Procedures and immunizations

- 1838-03-17 to 1838-03-17: Chest X-ray, two views: right upper lobe consolidation with a 2.5 cm thick-walled cavity and patchy opacities in the left upper zone; no effusion **S**
- 1838-03-17 to 1838-03-17: CT of the chest without contrast: a 2.5 cm thick-walled cavity in the apical segment of the right upper lobe with surrounding consolidation and tree-in-bud nodules in both upper lobes; no bronchiectasis, no emphysema, no enlarged lymph nodes, no effusion **S**
- 1835-10-04: Tetanus, diphtheria, and pertussis (Tdap) booster **S**

## Family history

- sister: Tuberculosis; died of it in 1827 **D** (CLM-0003)

## Measurements

Hemoglobin: 12.1 g/dL (low); White cell count: 9.6 10*3/uL; Platelets: 442 10*3/uL (high); ALT: 18 U/L; AST: 24 U/L; Total bilirubin: 0.5 mg/dL; Alkaline phosphatase: 84 U/L; Albumin: 3.2 g/dL (low); Creatinine: 0.78 mg/dL; eGFR: 125 mL/min/1.73 m²; Glucose: 86 mg/dL; Potassium: 4 mmol/L; Calcium: 9 mg/dL; Magnesium: 2 mg/dL; PHQ-9: 7; AUDIT-C: 2. All results are synthetic.

BP 104/66 mmHg; pulse 102 bpm; respirations 20/min; temperature 37.9 °C; oxygen saturation 95% on room air; weight 48.5 kg; BMI 16.8 kg/m². All vital signs are synthetic.

## Examination

Mental status: Quiet, courteous, and precise; organized thought; thin and tired; Mood low and anxious about the illness and his students; homesick; PHQ-9 7, with item 9 scored 0; no thoughts of suicide or self-harm. Functional status: Independent; has cut his teaching from about fifteen to eight lessons a week over the past month because of tiredness, cough, and night sweats. Physical examination is intentionally limited. **S**

## Assessment

1. Cough for about three months, blood-streaked sputum for two weeks, night sweats, and weight loss of about 6 kg in a man of 28, with a right upper lobe cavity on chest X-ray and CT: suspected pulmonary tuberculosis; home airborne isolation and three sputum samples for acid-fast smear, nucleic acid amplification, and culture; status draft. **S**
2. Moderate protein-calorie malnutrition: BMI 16.8, about 11 percent weight loss in three months, and albumin 3.2 g/dL; status draft. **S**

## Plan

- Infectious diseases consultation to confirm the diagnosis, choose between the six-month and four-month regimens, plan monitoring and his return to teaching, and address cystic fibrosis and alpha-1 antitrypsin deficiency as explanations for his lifelong chest illness. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022) **S**
- Diagnosis: three sputum samples at least eight hours apart, one early in the morning, for acid-fast smear, nucleic acid amplification with rifampin resistance, culture, molecular testing for isoniazid and fluoroquinolone resistance, and phenotypic susceptibility; an interferon-gamma release assay; HIV, hepatitis B, and hepatitis C tests; and baseline blood count, liver and kidney tests, potassium, calcium, and magnesium. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022) **S**
- Infection control and public health: home airborne isolation with no students or visitors and a surgical mask around others; same-day report of suspected tuberculosis to the health department; a contact investigation of his students, friends, and other close contacts led by the health department. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005) **S**
- Nutrition: two dietitian visits in the first month, three meals and three energy-dense snacks a day, two oral nutrition supplement drinks a day, and weight at every visit. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012) **S**
- Support: plain information about how tuberculosis spreads, how quickly treatment makes him non-infectious, and that it is curable; help with what to tell his students; PHQ-9 at diagnosis, at two months, and at the end of treatment. Guideline: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Guideline basis

- Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis (2016), American Thoracic Society, Centers for Disease Control and Prevention, and Infectious Diseases Society of America (Clinical Infectious Diseases)
- Interim Guidance: 4-Month Rifapentine-Moxifloxacin Regimen for the Treatment of Drug-Susceptible Pulmonary Tuberculosis - United States, 2022 (2022), Centers for Disease Control and Prevention (MMWR)
- Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC (2005), Centers for Disease Control and Prevention (MMWR Recommendations and Reports)
- Consensus statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the identification and documentation of adult malnutrition (undernutrition) (2012), Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition (JPEN)
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
